Fortunately, for pancreatic cancer patients and for those who love them, those days are over. Today (September 6), and for the next three days, a global contingent of researchers, clinicians, and physician-scientists are convening in Boston, Massachusetts, for the sixth AACR Special Conference on pancreatic cancer. This is where the latest information on a wide array of pancreatic cancer research and clinical trials will be shared among peers. Let’s Win and the Lustgarten Foundation will be providing brief highlights of the event over the weekend on our website as well as on Facebook and Twitter. And, of course, we will also be covering some of this innovative research in more depth during the upcoming months.
The conference promises to be jam-packed with more than 180 abstracts selected for poster presentation and three full-day plenary sessions, covering topics including the tumor microenvironment, genomics, immunology, early-stage trials– novel treatment combinations, and cancer metabolism, among others. “The incredible energy that I see in the whole arena of pancreatic cancer research is very gratifying,” says physician–scientist Dr. Allyson Ocean, Associate Professor of Clinical Medicine at Weill Cornell Medical College of Cornell University and medical oncologist and attending physician in gastrointestinal oncology, Solid Tumor Division, at New York-Presbyterian Hospital/Weill Cornell Medical Center, New York.
For Ocean and others, the purpose of the conference is very straightforward. “We all have one goal here and that’s to find out how we can do better for our patients,” says Ocean, who is also co-founder of Let’s Win and chair of the scientific advisory board. “Doing better by these patients is best achieved by being able to share data and being able to meet with the best minds in pancreatic cancer research. And that’s what is happening here in Boston this weekend. We will come away better scientists and better doctors.”
Lead supporters of the conference include the Lustgarten Foundation and the Pancreatic Cancer Action Network along with Ipsen and Let’s Win! Pancreatic Cancer. Professional educational grants have been provided by AstraZeneca, Celgene, Ipsen, and Merck.
Don’t forget to check Let’s Win for some of the latest updates from this important conference.